{"entity":{"type":"insider","cik":"0001285644","url":"/insider/0001285644","json_url":"/insider/0001285644.json","name":"ALTOMARI ALFRED","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":23,"first":"2007-05-10","last":"2022-08-29","span_basis":"filed_date"},"name_variants":[{"name":"ALTOMARI ALFRED","source":"filing","n_filings":23,"first_seen":"2007-05-10","last_seen":"2022-08-29"}],"transactions":[{"id":6745724,"accession":"0001104659-22-095384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-095384","line_url":"/filing/0001104659-22-095384#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","total_whole":"22,500","shares_owned_after":64343.0,"shares_owned_after_display":"64,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-26","filed_date":"2022-08-29","scope":"insider"},{"id":4130639,"accession":"0001104659-21-126012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-126012","line_url":"/filing/0001104659-21-126012#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58824.0,"shares_display":"58,824","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":573734.0,"shares_owned_after_display":"573,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-14","scope":"insider"},{"id":4720645,"accession":"0001104659-21-097783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-097783","line_url":"/filing/0001104659-21-097783#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26200.0,"shares_display":"26,200","price_per_share":1.2632,"price_display":"1.26","price_state":"stated","total_value":33095.84,"total_display":"33,095.84","total_whole":"33,096","shares_owned_after":514910.0,"shares_owned_after_display":"514,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-29","scope":"insider"},{"id":4458010,"accession":"0001104659-21-069099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-069099","line_url":"/filing/0001104659-21-069099#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.61,"price_display":"1.61","price_state":"stated","total_value":32200.0,"total_display":"32,200.00","total_whole":"32,200","shares_owned_after":488710.0,"shares_owned_after_display":"488,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-19","scope":"insider"},{"id":5141263,"accession":"0001104659-21-040396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-040396","line_url":"/filing/0001104659-21-040396#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":2.0024,"price_display":"2.00","price_state":"stated","total_value":25030.0,"total_display":"25,030.00","total_whole":"25,030","shares_owned_after":468710.0,"shares_owned_after_display":"468,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-23","filed_date":"2021-03-23","scope":"insider"},{"id":2173661,"accession":"0001104659-20-133640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-133640","line_url":"/filing/0001104659-20-133640#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":39.57,"price_display":"39.57","price_state":"stated","total_value":791400.0,"total_display":"791,400.00","total_whole":"791,400","shares_owned_after":20938.0,"shares_owned_after_display":"20,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-09","scope":"insider"},{"id":2114912,"accession":"0001192482-20-000795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000795","line_url":"/filing/0001192482-20-000795#line-1","is_derivative":false,"issuer_cik":"0001285644","issuer_name":"Baudax Bio, Inc.","issuer_ticker":"BXRX","issuer_name_source":null,"issuer_url":"/issuer/0001285644","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.0599,"price_display":"1.06","price_state":"stated","total_value":5299.5,"total_display":"5,299.50","total_whole":"5,300","shares_owned_after":61333.0,"shares_owned_after_display":"61,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-24","scope":"insider"},{"id":2311788,"accession":"0001192482-20-000259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000259","line_url":"/filing/0001192482-20-000259#line-1","is_derivative":false,"issuer_cik":"0001285644","issuer_name":"Baudax Bio, Inc.","issuer_ticker":"BXRX","issuer_name_source":null,"issuer_url":"/issuer/0001285644","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":11700.0,"total_display":"11,700.00","total_whole":"11,700","shares_owned_after":33382.0,"shares_owned_after_display":"33,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-26","filed_date":"2020-03-27","scope":"insider"},{"id":2424065,"accession":"0001104659-20-026463","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-026463","line_url":"/filing/0001104659-20-026463#line-2","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":27100.0,"total_display":"27,100.00","total_whole":"27,100","shares_owned_after":311611.0,"shares_owned_after_display":"311,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-02-27","scope":"insider"},{"id":7943456,"accession":"0001104659-19-034790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034790","line_url":"/filing/0001104659-19-034790#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.27,"price_display":"1.27","price_state":"stated","total_value":25400.0,"total_display":"25,400.00","total_whole":"25,400","shares_owned_after":258568.0,"shares_owned_after_display":"258,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2019-06-11","scope":"insider"},{"id":9223449,"accession":"0001104659-19-019002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-019002","line_url":"/filing/0001104659-19-019002#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":38500.0,"total_display":"38,500.00","total_whole":"38,500","shares_owned_after":238568.0,"shares_owned_after_display":"238,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-25","filed_date":"2019-04-01","scope":"insider"},{"id":8417015,"accession":"0001104659-19-017469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-017469","line_url":"/filing/0001104659-19-017469#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":38500.0,"total_display":"38,500.00","total_whole":"38,500","shares_owned_after":238568.0,"shares_owned_after_display":"238,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-25","filed_date":"2019-03-26","scope":"insider"},{"id":8667925,"accession":"0001127430-19-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127430-19-000040","line_url":"/filing/0001127430-19-000040#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":165000.0,"total_display":"165,000.00","total_whole":"165,000","shares_owned_after":25942.0,"shares_owned_after_display":"25,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-27","scope":"insider"},{"id":8421850,"accession":"0001127430-19-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127430-19-000032","line_url":"/filing/0001127430-19-000032#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":151250.0,"total_display":"151,250.00","total_whole":"151,250","shares_owned_after":31442.0,"shares_owned_after_display":"31,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-20","scope":"insider"},{"id":8476800,"accession":"0001127430-19-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127430-19-000029","line_url":"/filing/0001127430-19-000029#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":137500.0,"total_display":"137,500.00","total_whole":"137,500","shares_owned_after":36942.0,"shares_owned_after_display":"36,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-07","scope":"insider"},{"id":7913271,"accession":"0001127430-19-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127430-19-000025","line_url":"/filing/0001127430-19-000025#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":123750.0,"total_display":"123,750.00","total_whole":"123,750","shares_owned_after":42442.0,"shares_owned_after_display":"42,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-10","filed_date":"2019-01-14","scope":"insider"},{"id":5314082,"accession":"0001104659-17-054004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-054004","line_url":"/filing/0001104659-17-054004#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chairman & Chief Executive Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & Chief Executive Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.34,"price_display":"3.34","price_state":"stated","total_value":33400.0,"total_display":"33,400.00","total_whole":"33,400","shares_owned_after":161587.0,"shares_owned_after_display":"161,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-25","filed_date":"2017-08-28","scope":"insider"},{"id":4396932,"accession":"0001104659-17-032097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-032097","line_url":"/filing/0001104659-17-032097#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chairman and Chief Executive O)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and Chief Executive O","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":35100.0,"total_display":"35,100.00","total_whole":"35,100","shares_owned_after":151587.0,"shares_owned_after_display":"151,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-12","scope":"insider"},{"id":2651100,"accession":"0001123292-16-003064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-003064","line_url":"/filing/0001123292-16-003064#line-1","is_derivative":false,"issuer_cik":"0001285644","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001285644","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":6.55,"price_display":"6.55","price_state":"stated","total_value":9825.0,"total_display":"9,825.00","total_whole":"9,825","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-16","scope":"insider"},{"id":8271919,"accession":"0001104659-15-043013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-043013","line_url":"/filing/0001104659-15-043013#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":21825.0,"total_display":"21,825.00","total_whole":"21,825","shares_owned_after":78254.0,"shares_owned_after_display":"78,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-02","filed_date":"2015-06-03","scope":"insider"},{"id":8928930,"accession":"0001209191-11-043721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-043721","line_url":"/filing/0001209191-11-043721#line-1","is_derivative":false,"issuer_cik":"0000879993","issuer_name":"DUSA PHARMACEUTICALS INC","issuer_ticker":"DUSA","issuer_name_source":null,"issuer_url":"/issuer/0000879993","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.0596,"price_display":"4.06","price_state":"stated","total_value":8119.2,"total_display":"8,119.20","total_whole":"8,119","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-11","filed_date":"2011-08-11","scope":"insider"},{"id":7351742,"accession":"0001209191-10-041322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-041322","line_url":"/filing/0001209191-10-041322#line-1","is_derivative":false,"issuer_cik":"0000879993","issuer_name":"DUSA PHARMACEUTICALS INC","issuer_ticker":"DUSA","issuer_name_source":null,"issuer_url":"/issuer/0000879993","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":5040.0,"total_display":"5,040.00","total_whole":"5,040","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-05","filed_date":"2010-08-05","scope":"insider"},{"id":6999413,"accession":"0001209191-07-029260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-029260","line_url":"/filing/0001209191-07-029260#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001285644","owner_name":"ALTOMARI ALFRED","owner_display_name":"ALTOMARI ALFRED","owner_url":"/insider/0001285644","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":13.326,"price_display":"13.33","price_state":"stated","total_value":199890.0,"total_display":"199,890.00","total_whole":"199,890","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-08","filed_date":"2007-05-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001261249","name":"AGILE THERAPEUTICS INC","url":"/issuer/0001261249","role":"Director, Officer (Chief Executive Officer)","n_filings":12,"first_seen":"2015-06-03","last_seen":"2022-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001104506","name":"INSMED Inc","url":"/issuer/0001104506","role":"Director","n_filings":5,"first_seen":"2019-01-14","last_seen":"2020-12-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001780097","name":"Baudax Bio, Inc.","url":"/issuer/0001780097","role":"Director","n_filings":2,"first_seen":"2020-03-27","last_seen":"2020-11-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Director","n_filings":1,"first_seen":"2016-12-16","last_seen":"2016-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000879993","name":"DUSA PHARMACEUTICALS INC","url":"/issuer/0000879993","role":"Director","n_filings":2,"first_seen":"2010-08-05","last_seen":"2011-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Director","n_filings":1,"first_seen":"2007-05-10","last_seen":"2007-05-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001285644","retrieved_at":"2026-08-26T05:50:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}